Hyundai Pharmaceutical Co., Ltd. (KRX:004310)
South Korea · Delayed Price · Currency is KRW 8,820.00
+30.00 (0.34%)
Last updated: Apr 29, 2026, 2:20 PM KST
Hyundai Pharmaceutical Market Cap
Hyundai Pharmaceutical has a market cap or net worth of 243.29 billion as of April 28, 2026. Its market cap has increased by 183.55% in one year.
Market Cap
243.29B
Enterprise Value
n/a
Revenue
108.14B
Ranking
n/a
PE Ratio
145.68
Stock Price
8,820.00
Market Cap Chart
Since August 30, 1995, Hyundai Pharmaceutical's market cap has increased from 28.77B to 243.29B, an increase of 745.48%. That is a compound annual growth rate of 7.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 243.29B | 3.17% |
| Dec 30, 2025 | 235.81B | 137.66% |
| Dec 30, 2024 | 99.22B | -12.77% |
| Dec 28, 2023 | 113.76B | -14.20% |
| Dec 29, 2022 | 132.58B | -19.22% |
| Dec 30, 2021 | 164.12B | -22.93% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| JW Holdings | 303.75B |
| Korea United Pharm | 288.65B |
| BNC Korea | 285.21B |
| CMG Pharmaceutical | 268.19B |
| HLB Pharmaceutical | 247.85B |
| Boditech Med | 244.14B |
| Chong Kun Dang Holdings | 238.98B |
| Daewon Pharmaceutical | 234.27B |